SOPHiA GENETICS
SOPH
34 hedge funds and large institutions have $90.9M invested in SOPHiA GENETICS in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
127% more capital invested
Capital invested by funds: $40.1M → $90.9M (+$50.9M)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
6% more funds holding
Funds holding: 32 → 34 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.92% less ownership
Funds ownership: 30.41% → 28.49% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$364K |
| 3 |
PVI
Pura Vida Investments
New York
|
+$305K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$187K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$2.49M |
| 2 |
GE
General Electric
Evendale,
Ohio
|
-$2.29M |
| 3 |
FAM
Fred Alger Management
New York
|
-$314K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$115K |
| 5 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$82.4K |
SOPH Hedge Fund Activity: Q1 2023 in Review
34 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2023, worth a combined $90.9M — up 127% from $40.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SOPH positions and 3 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.1M. The largest seller was Jennison Associates, exiting entirely with an estimated $2.49M sold.
- 34 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2023, up from 32 in Q4 2022.
- Funds reported $90.9M of SOPHiA GENETICS stock for Q1 2023, up 127% quarter-over-quarter.
- 5 funds opened new SOPHiA GENETICS positions in Q1 2023 and 3 closed out, a net change of +2 holders.
- The largest SOPHiA GENETICS buyer in Q1 2023 was Millennium Management, an estimated $3.1M added.
- The largest SOPHiA GENETICS seller in Q1 2023 was Jennison Associates, an estimated $2.49M sold.
Based on aggregated 13F filings for Q1 2023.